Complication | ORa | 95% CI | P Value |
---|---|---|---|
Primary outcome: neurologic morbidity and neurologic mortality | 2.37 | 0.95 to 5.93 | .06 |
Secondary outcomes | |||
Spontaneous rupture | 1.46 | 0.28 to 7.67 | .65 |
Intracranial hemorrhage | 6.56 | 0.50 to 85.80 | .15 |
Ischemic stroke | 2.03 | 0.67 to 6.20 | .21 |
Parent artery stenosis | 0.06 | <0.001 to 24.51 | .37 |
Cranial neuropathy | 1.17 | 0.22 to 6.38 | .85 |
Neurologic mortality | 3.24 | 0.80 to 15.01 | .13 |
Neurologic morbidity | 3.25 | 1.10 to 9.61 | .03 |
All-cause mortality | 3.67 | 0.81 to 16.74 | .09 |
↵a Shown are the odds in the platelet testing/PED group versus those in the PED alone group. For each of the complications, the OR is for the platelet testing/PED versus the PED alone group. The analysis was adjusted for age, gender, aneurysm size, number of aneurysms treated, use of multiple PEDs, practitioner's previous experience, and center volume.